Global Antibody Drug Conjugate (ADC) Drug Market Research Report 2022

Publisher Name :
Date: 03-Aug-2022
No. of pages: 112
Inquire Before Buying

Antibody Drug Conjugate (ADC) Drug market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Antibody Drug Conjugate (ADC) Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

- by Technology

- - Mmunomedics Technology

- - Immunogen Technology

- - Seattle Genetics Technology

- - Others

- by Product Type

- - Kadcyla

- - Adcertis

Segment by Application

- Biotechnology Companies

- Specialized Cancer Centers

- Biopharmaceutical Companies

- Academic Research Institutes

- Hospitals

- Others

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Oxford Bio Therapeutics

- Synthon

- Progenics Pharmaceuticals

- Bayer HealthCare

- Millennium Pharmaceuticals

- Pfizer

- Concortis Bio therapeutics

- Roche Holding AG

- Seattle Genetics

- Heidelberg Pharma

- Mersana Therapeutics

- Astellas Pharma/Agensys

- AbbVie Inc

- Celldex Therapeutics

- Immunomedics

- Agensys

- Genentech

- ImmunoGen

- Sanofi

- Genmab

- Amgen

- Novartis

- Eli Lilly

Global Antibody Drug Conjugate (ADC) Drug Market Research Report 2022

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Technology
1.2.1 Global Antibody Drug Conjugate (ADC) Drug Market Size Growth Rate by Technology: 2017 VS 2021 VS 2028
1.2.2 Mmunomedics Technology
1.2.3 Immunogen Technology
1.2.4 Seattle Genetics Technology
1.2.5 Others
1.3 Market by Application
1.3.1 Global Antibody Drug Conjugate (ADC) Drug Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Biotechnology Companies
1.3.3 Specialized Cancer Centers
1.3.4 Biopharmaceutical Companies
1.3.5 Academic Research Institutes
1.3.6 Hospitals
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Antibody Drug Conjugate (ADC) Drug Market Perspective (2017-2028)
2.2 Antibody Drug Conjugate (ADC) Drug Growth Trends by Region
2.2.1 Antibody Drug Conjugate (ADC) Drug Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Antibody Drug Conjugate (ADC) Drug Historic Market Size by Region (2017-2022)
2.2.3 Antibody Drug Conjugate (ADC) Drug Forecasted Market Size by Region (2023-2028)
2.3 Antibody Drug Conjugate (ADC) Drug Market Dynamics
2.3.1 Antibody Drug Conjugate (ADC) Drug Industry Trends
2.3.2 Antibody Drug Conjugate (ADC) Drug Market Drivers
2.3.3 Antibody Drug Conjugate (ADC) Drug Market Challenges
2.3.4 Antibody Drug Conjugate (ADC) Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antibody Drug Conjugate (ADC) Drug Players by Revenue
3.1.1 Global Top Antibody Drug Conjugate (ADC) Drug Players by Revenue (2017-2022)
3.1.2 Global Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Players (2017-2022)
3.2 Global Antibody Drug Conjugate (ADC) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antibody Drug Conjugate (ADC) Drug Revenue
3.4 Global Antibody Drug Conjugate (ADC) Drug Market Concentration Ratio
3.4.1 Global Antibody Drug Conjugate (ADC) Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antibody Drug Conjugate (ADC) Drug Revenue in 2021
3.5 Antibody Drug Conjugate (ADC) Drug Key Players Head office and Area Served
3.6 Key Players Antibody Drug Conjugate (ADC) Drug Product Solution and Service
3.7 Date of Enter into Antibody Drug Conjugate (ADC) Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antibody Drug Conjugate (ADC) Drug Breakdown Data by Type
4.1 Global Antibody Drug Conjugate (ADC) Drug Historic Market Size by Type (2017-2022)
4.2 Global Antibody Drug Conjugate (ADC) Drug Forecasted Market Size by Type (2023-2028)
5 Antibody Drug Conjugate (ADC) Drug Breakdown Data by Application
5.1 Global Antibody Drug Conjugate (ADC) Drug Historic Market Size by Application (2017-2022)
5.2 Global Antibody Drug Conjugate (ADC) Drug Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Antibody Drug Conjugate (ADC) Drug Market Size (2017-2028)
6.2 North America Antibody Drug Conjugate (ADC) Drug Market Size by Country (2017-2022)
6.3 North America Antibody Drug Conjugate (ADC) Drug Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Antibody Drug Conjugate (ADC) Drug Market Size (2017-2028)
7.2 Europe Antibody Drug Conjugate (ADC) Drug Market Size by Country (2017-2022)
7.3 Europe Antibody Drug Conjugate (ADC) Drug Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antibody Drug Conjugate (ADC) Drug Market Size (2017-2028)
8.2 Asia-Pacific Antibody Drug Conjugate (ADC) Drug Market Size by Country (2017-2022)
8.3 Asia-Pacific Antibody Drug Conjugate (ADC) Drug Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Antibody Drug Conjugate (ADC) Drug Market Size (2017-2028)
9.2 Latin America Antibody Drug Conjugate (ADC) Drug Market Size by Country (2017-2022)
9.3 Latin America Antibody Drug Conjugate (ADC) Drug Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size (2017-2028)
10.2 Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size by Country (2017-2022)
10.3 Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Oxford Bio Therapeutics
11.1.1 Oxford Bio Therapeutics Company Detail
11.1.2 Oxford Bio Therapeutics Business Overview
11.1.3 Oxford Bio Therapeutics Antibody Drug Conjugate (ADC) Drug Introduction
11.1.4 Oxford Bio Therapeutics Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.1.5 Oxford Bio Therapeutics Recent Development
11.2 Synthon
11.2.1 Synthon Company Detail
11.2.2 Synthon Business Overview
11.2.3 Synthon Antibody Drug Conjugate (ADC) Drug Introduction
11.2.4 Synthon Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.2.5 Synthon Recent Development
11.3 Progenics Pharmaceuticals
11.3.1 Progenics Pharmaceuticals Company Detail
11.3.2 Progenics Pharmaceuticals Business Overview
11.3.3 Progenics Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Introduction
11.3.4 Progenics Pharmaceuticals Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.3.5 Progenics Pharmaceuticals Recent Development
11.4 Bayer HealthCare
11.4.1 Bayer HealthCare Company Detail
11.4.2 Bayer HealthCare Business Overview
11.4.3 Bayer HealthCare Antibody Drug Conjugate (ADC) Drug Introduction
11.4.4 Bayer HealthCare Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.4.5 Bayer HealthCare Recent Development
11.5 Millennium Pharmaceuticals
11.5.1 Millennium Pharmaceuticals Company Detail
11.5.2 Millennium Pharmaceuticals Business Overview
11.5.3 Millennium Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Introduction
11.5.4 Millennium Pharmaceuticals Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.5.5 Millennium Pharmaceuticals Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Detail
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Antibody Drug Conjugate (ADC) Drug Introduction
11.6.4 Pfizer Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.6.5 Pfizer Recent Development
11.7 Concortis Bio therapeutics
11.7.1 Concortis Bio therapeutics Company Detail
11.7.2 Concortis Bio therapeutics Business Overview
11.7.3 Concortis Bio therapeutics Antibody Drug Conjugate (ADC) Drug Introduction
11.7.4 Concortis Bio therapeutics Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.7.5 Concortis Bio therapeutics Recent Development
11.8 Roche Holding AG
11.8.1 Roche Holding AG Company Detail
11.8.2 Roche Holding AG Business Overview
11.8.3 Roche Holding AG Antibody Drug Conjugate (ADC) Drug Introduction
11.8.4 Roche Holding AG Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.8.5 Roche Holding AG Recent Development
11.9 Seattle Genetics
11.9.1 Seattle Genetics Company Detail
11.9.2 Seattle Genetics Business Overview
11.9.3 Seattle Genetics Antibody Drug Conjugate (ADC) Drug Introduction
11.9.4 Seattle Genetics Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.9.5 Seattle Genetics Recent Development
11.10 Heidelberg Pharma
11.10.1 Heidelberg Pharma Company Detail
11.10.2 Heidelberg Pharma Business Overview
11.10.3 Heidelberg Pharma Antibody Drug Conjugate (ADC) Drug Introduction
11.10.4 Heidelberg Pharma Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.10.5 Heidelberg Pharma Recent Development
11.11 Mersana Therapeutics
11.11.1 Mersana Therapeutics Company Detail
11.11.2 Mersana Therapeutics Business Overview
11.11.3 Mersana Therapeutics Antibody Drug Conjugate (ADC) Drug Introduction
11.11.4 Mersana Therapeutics Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.11.5 Mersana Therapeutics Recent Development
11.12 Astellas Pharma/Agensys
11.12.1 Astellas Pharma/Agensys Company Detail
11.12.2 Astellas Pharma/Agensys Business Overview
11.12.3 Astellas Pharma/Agensys Antibody Drug Conjugate (ADC) Drug Introduction
11.12.4 Astellas Pharma/Agensys Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.12.5 Astellas Pharma/Agensys Recent Development
11.13 AbbVie Inc
11.13.1 AbbVie Inc Company Detail
11.13.2 AbbVie Inc Business Overview
11.13.3 AbbVie Inc Antibody Drug Conjugate (ADC) Drug Introduction
11.13.4 AbbVie Inc Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.13.5 AbbVie Inc Recent Development
11.14 Celldex Therapeutics
11.14.1 Celldex Therapeutics Company Detail
11.14.2 Celldex Therapeutics Business Overview
11.14.3 Celldex Therapeutics Antibody Drug Conjugate (ADC) Drug Introduction
11.14.4 Celldex Therapeutics Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.14.5 Celldex Therapeutics Recent Development
11.15 Immunomedics
11.15.1 Immunomedics Company Detail
11.15.2 Immunomedics Business Overview
11.15.3 Immunomedics Antibody Drug Conjugate (ADC) Drug Introduction
11.15.4 Immunomedics Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.15.5 Immunomedics Recent Development
11.16 Agensys
11.16.1 Agensys Company Detail
11.16.2 Agensys Business Overview
11.16.3 Agensys Antibody Drug Conjugate (ADC) Drug Introduction
11.16.4 Agensys Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.16.5 Agensys Recent Development
11.17 Genentech
11.17.1 Genentech Company Detail
11.17.2 Genentech Business Overview
11.17.3 Genentech Antibody Drug Conjugate (ADC) Drug Introduction
11.17.4 Genentech Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.17.5 Genentech Recent Development
11.18 ImmunoGen
11.18.1 ImmunoGen Company Detail
11.18.2 ImmunoGen Business Overview
11.18.3 ImmunoGen Antibody Drug Conjugate (ADC) Drug Introduction
11.18.4 ImmunoGen Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.18.5 ImmunoGen Recent Development
11.19 Sanofi
11.19.1 Sanofi Company Detail
11.19.2 Sanofi Business Overview
11.19.3 Sanofi Antibody Drug Conjugate (ADC) Drug Introduction
11.19.4 Sanofi Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.19.5 Sanofi Recent Development
11.20 Genmab
11.20.1 Genmab Company Detail
11.20.2 Genmab Business Overview
11.20.3 Genmab Antibody Drug Conjugate (ADC) Drug Introduction
11.20.4 Genmab Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.20.5 Genmab Recent Development
11.21 Amgen
11.21.1 Amgen Company Detail
11.21.2 Amgen Business Overview
11.21.3 Amgen Antibody Drug Conjugate (ADC) Drug Introduction
11.21.4 Amgen Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.21.5 Amgen Recent Development
11.22 Novartis
11.22.1 Novartis Company Detail
11.22.2 Novartis Business Overview
11.22.3 Novartis Antibody Drug Conjugate (ADC) Drug Introduction
11.22.4 Novartis Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.22.5 Novartis Recent Development
11.23 Eli Lilly
11.23.1 Eli Lilly Company Detail
11.23.2 Eli Lilly Business Overview
11.23.3 Eli Lilly Antibody Drug Conjugate (ADC) Drug Introduction
11.23.4 Eli Lilly Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.23.5 Eli Lilly Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Antibody Drug Conjugate (ADC) Drug Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Mmunomedics Technology
Table 3. Key Players of Immunogen Technology
Table 4. Key Players of Seattle Genetics Technology
Table 5. Key Players of Others
Table 6. Global Antibody Drug Conjugate (ADC) Drug Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Antibody Drug Conjugate (ADC) Drug Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Antibody Drug Conjugate (ADC) Drug Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Antibody Drug Conjugate (ADC) Drug Market Share by Region (2017-2022)
Table 10. Global Antibody Drug Conjugate (ADC) Drug Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Antibody Drug Conjugate (ADC) Drug Market Share by Region (2023-2028)
Table 12. Antibody Drug Conjugate (ADC) Drug Market Trends
Table 13. Antibody Drug Conjugate (ADC) Drug Market Drivers
Table 14. Antibody Drug Conjugate (ADC) Drug Market Challenges
Table 15. Antibody Drug Conjugate (ADC) Drug Market Restraints
Table 16. Global Antibody Drug Conjugate (ADC) Drug Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Antibody Drug Conjugate (ADC) Drug Market Share by Players (2017-2022)
Table 18. Global Top Antibody Drug Conjugate (ADC) Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Drug Conjugate (ADC) Drug as of 2021)
Table 19. Ranking of Global Top Antibody Drug Conjugate (ADC) Drug Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Antibody Drug Conjugate (ADC) Drug Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Antibody Drug Conjugate (ADC) Drug Product Solution and Service
Table 23. Date of Enter into Antibody Drug Conjugate (ADC) Drug Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Antibody Drug Conjugate (ADC) Drug Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Type (2017-2022)
Table 27. Global Antibody Drug Conjugate (ADC) Drug Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Type (2023-2028)
Table 29. Global Antibody Drug Conjugate (ADC) Drug Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Application (2017-2022)
Table 31. Global Antibody Drug Conjugate (ADC) Drug Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Application (2023-2028)
Table 33. North America Antibody Drug Conjugate (ADC) Drug Market Size by Country (2017-2022) & (US$ Million)
Table 34. North America Antibody Drug Conjugate (ADC) Drug Market Size by Country (2023-2028) & (US$ Million)
Table 35. Europe Antibody Drug Conjugate (ADC) Drug Market Size by Country (2017-2022) & (US$ Million)
Table 36. Europe Antibody Drug Conjugate (ADC) Drug Market Size by Country (2023-2028) & (US$ Million)
Table 37. Asia-Pacific Antibody Drug Conjugate (ADC) Drug Market Size by Region (2017-2022) & (US$ Million)
Table 38. Asia-Pacific Antibody Drug Conjugate (ADC) Drug Market Size by Region (2023-2028) & (US$ Million)
Table 39. Latin America Antibody Drug Conjugate (ADC) Drug Market Size by Country (2017-2022) & (US$ Million)
Table 40. Latin America Antibody Drug Conjugate (ADC) Drug Market Size by Country (2023-2028) & (US$ Million)
Table 41. Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size by Country (2017-2022) & (US$ Million)
Table 42. Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size by Country (2023-2028) & (US$ Million)
Table 43. Oxford Bio Therapeutics Company Detail
Table 44. Oxford Bio Therapeutics Business Overview
Table 45. Oxford Bio Therapeutics Antibody Drug Conjugate (ADC) Drug Product
Table 46. Oxford Bio Therapeutics Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 47. Oxford Bio Therapeutics Recent Development
Table 48. Synthon Company Detail
Table 49. Synthon Business Overview
Table 50. Synthon Antibody Drug Conjugate (ADC) Drug Product
Table 51. Synthon Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 52. Synthon Recent Development
Table 53. Progenics Pharmaceuticals Company Detail
Table 54. Progenics Pharmaceuticals Business Overview
Table 55. Progenics Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Product
Table 56. Progenics Pharmaceuticals Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 57. Progenics Pharmaceuticals Recent Development
Table 58. Bayer HealthCare Company Detail
Table 59. Bayer HealthCare Business Overview
Table 60. Bayer HealthCare Antibody Drug Conjugate (ADC) Drug Product
Table 61. Bayer HealthCare Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 62. Bayer HealthCare Recent Development
Table 63. Millennium Pharmaceuticals Company Detail
Table 64. Millennium Pharmaceuticals Business Overview
Table 65. Millennium Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Product
Table 66. Millennium Pharmaceuticals Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 67. Millennium Pharmaceuticals Recent Development
Table 68. Pfizer Company Detail
Table 69. Pfizer Business Overview
Table 70. Pfizer Antibody Drug Conjugate (ADC) Drug Product
Table 71. Pfizer Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 72. Pfizer Recent Development
Table 73. Concortis Bio therapeutics Company Detail
Table 74. Concortis Bio therapeutics Business Overview
Table 75. Concortis Bio therapeutics Antibody Drug Conjugate (ADC) Drug Product
Table 76. Concortis Bio therapeutics Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 77. Concortis Bio therapeutics Recent Development
Table 78. Roche Holding AG Company Detail
Table 79. Roche Holding AG Business Overview
Table 80. Roche Holding AG Antibody Drug Conjugate (ADC) Drug Product
Table 81. Roche Holding AG Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 82. Roche Holding AG Recent Development
Table 83. Seattle Genetics Company Detail
Table 84. Seattle Genetics Business Overview
Table 85. Seattle Genetics Antibody Drug Conjugate (ADC) Drug Product
Table 86. Seattle Genetics Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 87. Seattle Genetics Recent Development
Table 88. Heidelberg Pharma Company Detail
Table 89. Heidelberg Pharma Business Overview
Table 90. Heidelberg Pharma Antibody Drug Conjugate (ADC) Drug Product
Table 91. Heidelberg Pharma Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 92. Heidelberg Pharma Recent Development
Table 93. Mersana Therapeutics Company Detail
Table 94. Mersana Therapeutics Business Overview
Table 95. Mersana Therapeutics Antibody Drug Conjugate (ADC) DrugProduct
Table 96. Mersana Therapeutics Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 97. Mersana Therapeutics Recent Development
Table 98. Astellas Pharma/Agensys Company Detail
Table 99. Astellas Pharma/Agensys Business Overview
Table 100. Astellas Pharma/Agensys Antibody Drug Conjugate (ADC) DrugProduct
Table 101. Astellas Pharma/Agensys Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 102. Astellas Pharma/Agensys Recent Development
Table 103. AbbVie Inc Company Detail
Table 104. AbbVie Inc Business Overview
Table 105. AbbVie Inc Antibody Drug Conjugate (ADC) DrugProduct
Table 106. AbbVie Inc Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 107. AbbVie Inc Recent Development
Table 108. Celldex Therapeutics Company Detail
Table 109. Celldex Therapeutics Business Overview
Table 110. Celldex Therapeutics Antibody Drug Conjugate (ADC) DrugProduct
Table 111. Celldex Therapeutics Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 112. Celldex Therapeutics Recent Development
Table 113. Immunomedics Company Detail
Table 114. Immunomedics Business Overview
Table 115. Immunomedics Antibody Drug Conjugate (ADC) DrugProduct
Table 116. Immunomedics Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 117. Immunomedics Recent Development
Table 118. Agensys Company Detail
Table 119. Agensys Business Overview
Table 120. Agensys Antibody Drug Conjugate (ADC) DrugProduct
Table 121. Agensys Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 122. Agensys Recent Development
Table 123. Genentech Company Detail
Table 124. Genentech Business Overview
Table 125. Genentech Antibody Drug Conjugate (ADC) DrugProduct
Table 126. Genentech Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 127. Genentech Recent Development
Table 128. ImmunoGen Company Detail
Table 129. ImmunoGen Business Overview
Table 130. ImmunoGen Antibody Drug Conjugate (ADC) DrugProduct
Table 131. ImmunoGen Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 132. ImmunoGen Recent Development
Table 133. Sanofi Company Detail
Table 134. Sanofi Business Overview
Table 135. Sanofi Antibody Drug Conjugate (ADC) DrugProduct
Table 136. Sanofi Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 137. Sanofi Recent Development
Table 138. Genmab Company Detail
Table 139. Genmab Business Overview
Table 140. Genmab Antibody Drug Conjugate (ADC) DrugProduct
Table 141. Genmab Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 142. Genmab Recent Development
Table 143. Amgen Company Detail
Table 144. Amgen Business Overview
Table 145. Amgen Antibody Drug Conjugate (ADC) DrugProduct
Table 146. Amgen Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 147. Amgen Recent Development
Table 148. Novartis Company Detail
Table 149. Novartis Business Overview
Table 150. Novartis Antibody Drug Conjugate (ADC) DrugProduct
Table 151. Novartis Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 152. Novartis Recent Development
Table 153. Eli Lilly Company Detail
Table 154. Eli Lilly Business Overview
Table 155. Eli Lilly Antibody Drug Conjugate (ADC) DrugProduct
Table 156. Eli Lilly Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 157. Eli Lilly Recent Development
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antibody Drug Conjugate (ADC) Drug Market Share by Type: 2021 VS 2028
Figure 2. Mmunomedics Technology Features
Figure 3. Immunogen Technology Features
Figure 4. Seattle Genetics Technology Features
Figure 5. Others Features
Figure 6. Global Antibody Drug Conjugate (ADC) Drug Market Share by Application in 2021 & 2028
Figure 7. Biotechnology Companies Case Studies
Figure 8. Specialized Cancer Centers Case Studies
Figure 9. Biopharmaceutical Companies Case Studies
Figure 10. Academic Research Institutes Case Studies
Figure 11. Hospitals Case Studies
Figure 12. Others Case Studies
Figure 13. Antibody Drug Conjugate (ADC) Drug Report Years Considered
Figure 14. Global Antibody Drug Conjugate (ADC) Drug Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 15. Global Antibody Drug Conjugate (ADC) Drug Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Antibody Drug Conjugate (ADC) Drug Market Share by Region: 2021 VS 2028
Figure 17. Global Antibody Drug Conjugate (ADC) Drug Market Share by Players in 2021
Figure 18. Global Top Antibody Drug Conjugate (ADC) Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Drug Conjugate (ADC) Drug as of 2021)
Figure 19. The Top 10 and 5 Players Market Share by Antibody Drug Conjugate (ADC) Drug Revenue in 2021
Figure 20. North America Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. North America Antibody Drug Conjugate (ADC) Drug Market Share by Country (2017-2028)
Figure 22. United States Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Europe Antibody Drug Conjugate (ADC) Drug Market Share by Country (2017-2028)
Figure 26. Germany Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Antibody Drug Conjugate (ADC) Drug Market Share by Region (2017-2028)
Figure 34. China Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Japan Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. South Korea Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Southeast Asia Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. India Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Australia Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Latin America Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Latin America Antibody Drug Conjugate (ADC) Drug Market Share by Country (2017-2028)
Figure 42. Mexico Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Brazil Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Share by Country (2017-2028)
Figure 46. Turkey Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Saudi Arabia Antibody Drug Conjugate (ADC) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Oxford Bio Therapeutics Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
Figure 49. Synthon Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
Figure 50. Progenics Pharmaceuticals Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
Figure 51. Bayer HealthCare Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
Figure 52. Millennium Pharmaceuticals Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
Figure 53. Pfizer Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
Figure 54. Concortis Bio therapeutics Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
Figure 55. Roche Holding AG Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
Figure 56. Seattle Genetics Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
Figure 57. Heidelberg Pharma Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
Figure 58. Mersana Therapeutics Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
Figure 59. Astellas Pharma/Agensys Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
Figure 60. AbbVie Inc Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
Figure 61. Celldex Therapeutics Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
Figure 62. Immunomedics Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
Figure 63. Agensys Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
Figure 64. Genentech Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
Figure 65. ImmunoGen Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
Figure 66. Sanofi Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
Figure 67. Genmab Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
Figure 68. Amgen Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
Figure 69. Novartis Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
Figure 70. Eli Lilly Revenue Growth Rate in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
  • Global Microstream Capnography Equipment Market Research Report 2022
    Published: 12-Aug-2022        Price: US 2900 Onwards        Pages: 99
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Desktop Type - Portable Type Segment by Application - Critical Care - Emergency Medic......
  • Global Long-Term Therapeutic Bed Market Research Report 2022
    Published: 12-Aug-2022        Price: US 2900 Onwards        Pages: 90
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Mechanical Type - Electric Type Segment by Application - Home - Hospital ......
  • Global Mainstream Capnography Equipment Market Research Report 2022
    Published: 12-Aug-2022        Price: US 2900 Onwards        Pages: 95
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Desktop Type - Portable Type Segment by Application - Critical Care - Emergency Medic......
  • Global Critical Care Therapeutic Bed Market Research Report 2022
    Published: 12-Aug-2022        Price: US 2900 Onwards        Pages: 94
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Mechanical Type - Electric Type Segment by Application - Home - Hospital ......
  • Global Manual Wound Irrigation System Market Research Report 2022
    Published: 12-Aug-2022        Price: US 2900 Onwards        Pages: 118
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Disposable - Reusable Segment by Application - Outpatient Surgery Center - Hospital......
  • Global Wrist-worn Pulse Oximeter Market Research Report 2022
    Published: 12-Aug-2022        Price: US 2900 Onwards        Pages: 98
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Separate Sensor - Intergated Sensor Segment by Application - Hospital - Ambulatory Su......
  • Global Medical Wellness Device Market Research Report 2022
    Published: 12-Aug-2022        Price: US 2900 Onwards        Pages: 109
    Medical Wellness Device market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Medical Wellness Device market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Sphygmomanometer - Diabetes Monitoring Equipment - Pulse Oxime......
  • Global Disposable EEG Electrode Market Research Report 2022
    Published: 12-Aug-2022        Price: US 2900 Onwards        Pages: 89
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Cup Electrode - Patch Electrode - Disk Electrode - Other Segment by Application......
  • Global Leukapheresis Products Market Research Report 2022
    Published: 12-Aug-2022        Price: US 2900 Onwards        Pages: 92
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Leukapheresis Disposables - Apheresis Devices - Leukoreduction Filters Segment by Applicatio......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs